Heavy tamponade 1: a review of indications, use, and complications

被引:93
作者
Heimann, H. [1 ]
Stappler, T. [1 ]
Wong, D. [1 ]
机构
[1] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool L7 8XP, Merseyside, England
关键词
heavy tamponade; heavy silicone oil; proliferative vitreoretinopathy; retinal detachment;
D O I
10.1038/eye.2008.61
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Heavier than water intraocular tamponades have several theoretical advantages over conventional tamponades, especially in the treatment of complicated retinal detachments and proliferative viteroretinopathy of the lower fundus periphery. However, initial clinical series of various heavy tamponades have reported significant complication rates. Therefore, heavy tamponades have not found widespread acceptance. Three recently developed heavy silicone oil tamponades, Oxane HD, Densiron 68, and HWS 46-3000, are much better tolerated and presently seem to enter routine clinical practice. Materials and methods Literature review of 21 publications on the clinical application of 9 different heavy tamponades (fluorosilicone, C10F18, F6H8, OL62HV, Oxane HD, O62, F6H8-silicone oil mixture, Densiron 68, and HWS 46-3000). Results The first generation (fluorinated silicone and perfluorocarbon liquids) and second generation (partially fluorinated alkanes) of heavy tamponades were associated with relatively high complication rates, for example, tamponade emulsification, intraocular inflammation, and rise in intraocular pressure. The complication spectrum of the new generation of heavy silicone oils (Oxane HD, Densiron 68, and HWS 46-3000) seems to be comparable to conventional silicone oil tamponades while providing better support for the inferior retina and the posterior pole. Conclusion The recently developed heavy silicone oil tamponades are safe and effective tools for the use of complicated retinal detachments of the inferior fundus.
引用
收藏
页码:1342 / 1359
页数:18
相关论文
共 62 条
  • [1] ALEXANDER P, 2007, EYE 0202
  • [2] Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy - Results from a randomized, double-blind, controlled clinical trial
    Asaria, RHY
    Kon, CH
    Bunce, C
    Charteris, DG
    Wong, D
    Khaw, PT
    Aylward, GW
    [J]. OPHTHALMOLOGY, 2001, 108 (07) : 1179 - 1183
  • [3] Batman C, 1998, OPHTHALMIC SURG LAS, V29, P144
  • [4] Bhisitkul RB, 2005, BRIT J OPHTHALMOL, V89, P649, DOI 10.1136/bjo.2004.057182
  • [5] BOTTONI F, 1994, OPHTHALMIC SURG LAS, V25, P365
  • [6] PERFLUOROCARBON LIQUIDS AS POSTOPERATIVE SHORT-TERM VITREOUS SUBSTITUTES IN COMPLICATED RETINAL-DETACHMENT
    BOTTONI, F
    SBORGIA, M
    ARPA, P
    DECASA, N
    BERTAZZI, E
    MONTICELLI, M
    DEMOLFETTA, V
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1993, 231 (11) : 619 - 628
  • [7] COMBINED SILICONE AND FLUOROSILICONE OIL TAMPONADE (DOUBLE FILLING) IN THE MANAGEMENT OF COMPLICATED RETINAL-DETACHMENT
    BOTTONI, F
    ARPA, P
    VINCIGUERRA, P
    ZENONI, S
    DEMOLFETTA, V
    [J]. OPHTHALMOLOGICA, 1992, 204 (02) : 77 - &
  • [8] INTRAOPERATIVE PERFLUOROCARBON LIQUIDS IN THE MANAGEMENT OF PROLIFERATIVE VITREORETINOPATHY
    CHANG, S
    OZMERT, E
    ZIMMERMAN, NJ
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1988, 106 (06) : 668 - 674
  • [9] Cheung BTO, 2007, BRIT J OPHTHALMOL, V91, P719, DOI 10.1136/bjo.2006.111526
  • [10] THE EFFECT OF SIMULTANEOUS INTERNAL TAMPONADE ON FLUID COMPARTMENTALIZATION AND ITS RELATIONSHIP TO CELL-PROLIFERATION
    DEMOLFETTA, V
    BOTTONI, F
    ARPA, P
    VINCIGUERRA, P
    ZENONI, S
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1992, 12 (03): : S40 - S45